Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease

Circulation

Volumn 101, Issue 12, 2000, Pages 1465-1478

  Beller, George A ^a   Zaret, Barry L ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

Coronary disease; Imaging; Technetium 99m sestamibi; Thallium 201

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 15 (4 IODOPHENYL) 3 METHYLPENTADECANOIC ACID I 123; ADENOSINE; ADENOSINE DERIVATIVE; AMMONIA; ANTIBODY; ANTISENSE OLIGODEOXYNUCLEOTIDE; BETA METHYLIODOPHENYL PENTADECANOIC ACID IODINE I 123; DIPYRIDAMOLE; DOBUTAMINE; ENDOTHELIN DERIVATIVE; FLUORODEOXYGLUCOSE F 18; GLUCARATE TECHNETIUM TC 99M; IODOPHENYL PENTADECANOIC ACID IODINE I 123; LIPOCORTIN 5; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITROGEN 13; OXIDIZED LOW DENSITY LIPOPROTEIN; POLYPHOSPHATE; PYROPHOSPHATE TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT; TECHNETIUM 99M; TETROFOSMIN TC 99M; THALLIUM 201; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CORONARY ARTERY DISEASE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DRUG METABOLISM; DYSPNEA; EXERCISE; HEADACHE; HEART BLOCK; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; HYPEREMIA; INSTRUMENTATION; MENTAL STRESS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURVIVAL; THORAX PAIN;

EID: 0034724308     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.12.1465     Document Type: Article

References (105)

1. Beller GA. Radionuclide perfusion imaging techniques for evaluation of patients with known or suspected coronary artery disease. Adv Intern Med. 1997;42:139-201.
2. DePuey EG, Rozanski A. Using gated technetium-99m-sestamibi SPECT to characterize fixed myocardial defects as infarct or artifact. J Nucl Med. 1995;36:952-955.
3. 201T1 and myocardial blood flow. Circulation. 1997;96:2325-2331.
4. Mahmarian JJ. State of the art for coronary artery disease detection: thallium-201. In: Zaret BL, Beller GA, eds. Nuclear Cardiology: State of the Art and Future Directions. 2nd ed. St Louis, Mo: Mosby; 1999: 237-272.
5. Beller GA. Current status of nuclear cardiology techniques. Curr Probl Cardiol. 1991;16:451-535.
6. Mahmarian JJ, Steingart RM, Forman S, Sharaf BL, Coglianese ME, Miller DD, Pepine CJ, Goldberg AD, Bloom MF, Byers S, Dvorak L, Pratt CM. Relation between ambulatory electrocardiographic monitoring and myocardial perfusion imaging to detect coronary artery disease and myocardial ischemia: an ACIP ancillary study: the Asymptomatic Cardiac Ischemia Pilot (ACIP) Investigators. J Am Coll Cardiol. 1997;29:764-769.
7. Taillefer R, DePuey EG, Udelson JE, Beller GA, Latour Y, Reeves F. Comparative diagnostic accuracy of T1-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women. J Am Coll Cardiol. 1997;29:69-77.
8. Smanio PEP, Watson DD, Segalla DL, Vinson EL, Smith WH, Beller GA. Value of gating of technetium-99m sestamibi single-photon emission computed tomographic imaging. J Am Coll Cardiol. 1997;30: 1687-1692.
9. Germano G, Erel J, Kiat H, Kavanagh PB, Berman DS. Quantitative LVEF and qualitative regional function from gated thallium-201 perfusion SPECT. J Nucl Med. 1997;38:749-754.
10. Calnon DA, Kastner RJ, Smith WH, Segalla D, Beller GA, Watson DD. Validation of a new counts-based gated single photon emission computed tomography method for quantifying left ventricular systolic function: comparison with equilibrium radionuclide angiography. J Nucl Cardiol. 1997;4:464-471.
11. Maddahi J, Kiat H, Friedman JD, Berman DS, Van Train KF, Garcia EV. Technetium-99m-sestamibi myocardial perfusion imaging for evaluation of coronary artery disease. In: Zaret BL, Beller GA, eds. Nuclear Cardiology: State of the Art and Future Directions. 1st ed. St Louis, Mo: Mosby-Year Book; 1993:191-200.
12. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, Maddahi J, Germano G. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455-1464.
13. O'Keefe JH Jr, Barnhart CS, Bateman TM. Comparison of stress echocardiography and stress myocardial perfusion scintigraphy for diagnosing coronary artery disease and assessing its severity. Am J Cardiol. 1995;75:25D-34D.
14. Iskandrian AE, Heo J, Nallamothu N. Detection of coronary artery disease in women with use of stress single-photon emission computed tomography myocardial perfusion imaging. J Nucl Cardiol. 1997;4: 329-335.
15. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol. 1994;23: 384-389.
16. 2A receptor agonist. Circulation. 1996;94:1726-1732.
17. Hays JT, Mahmarian JJ, Cochran AJ, Verani MS. Dobutamine thallium-201 tomography for evaluating patients with suspected coronary artery disease unable to undergo exercise or vasodilator pharmacologic stress testing. J Am Coll Cardiol. 1993;21:1583-1590.
18. Gianrossi R, Detrano R, Mulvihill D, Lehmann K, Dubach P, Colombo A, McArthur D, Froelicher V. Exercise-induced ST depression in the diagnosis of coronary artery disease: a meta-analysis. Circulation. 1989; 80:87-98.
19. Brown KA. Prognosis in stable coronary artery disease. In: Zaret BL, Beller GA, eds. Nuclear Cardiology: State of the Art and Future Directions. 2nd ed. St Louis, Mo: Mosby; 1999:331-345.
20. Gibbons RS. American Society of Nuclear Cardiology project on myocardial perfusion imaging: measuring outcomes in response to emerging guidelines. J Nucl Cardiol. 1996;3:436-442. Editorial.
21. Brown KA, Boucher CA, Okada RD, Guiney TE, Newell JB, Strauss HW, Pohost GM. Prognostic value of exercise thallium-201 imaging in patients presenting for evaluation of chest pain. J Am Coll Cardiol. 1983;1:994-1001.
22. Ladenheim ML, Pollock BH, Rozanski A, Berman DS, Staniloff HM, Forrester JS, Diamond GA. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7:464-471.
23. Pollock SG, Abbott RD, Boucher CA, Beller GA, Kaul S. Independent and incremental prognostic value of tests performed in hierarchical order to evaluate patients with suspected coronary artery disease: validation of models based on these tests. Circulation. 1992;85:237-248.
24. Iskandrian AS, Chae SC, Heo J, Stanberry CD, Wasserleben V, Cave V. Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. J Am Coll Cardiol. 1993;22:665-670.
25. Machecourt J, Longère P, Fagret D, Vanzetto G, Wolf JE, Polidori C, Comet M, Denis B. Prognostic value of thallium-201 single-photon emission computed tomographic myocardial perfusion imaging according to extent of myocardial defect: study in 1,926 patients with follow-up at 33 months. J Am Coll Cardiol. 1994;23:1096-1106.
26. Iskander S, Iskandrian AE. Risk assessment using single-photon emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol. 1998;32:57-62.
27. Berman DS, Hachamovitch R, Kiat H, Cohen I, Cabico JA, Wang FP, Friedman JD, Germano G, Van Train K, Diamond GA. Incremental value of prognostic testing in patients with known or suspected ischemic heart disease: a basis for optimal utilization of exercise technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography [published erratum appears in J Am Coll Cardiol. 1996; 27:756]. J Am Coll Cardiol. 1995;26:639-647.
28. Hachamovitch R, Berman DS, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 1996;93:905-914.
29. Hachamovitch R, Berman DS, Kiat H, Bairey CN, Cohen I, Cabico A, Friedman J, Germano G, Van Train KF, Diamond GA. Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol. 1996;28:34-44.
30. Marwick TH, Shaw LJ, Lauer MS, Kesler K, Hachamovitch R, Heller GV, Travin MI, Borges-Neto S, Berman DS, Miller DD. The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease: Economics of Noninvasive Diagnosis (END) Study Group. Am J Med. 1999;106:172-178.
31. Boyne TS, Koplan BA, Parsons WJ, Smith WH, Watson DD, Beller GA. Predicting adverse outcome with exercise SPECT technetium-99m sestamibi imaging in patients with suspected or known coronary artery disease. Am J Cardiol. 1997;79:270-274.
32. Chatziioannou SN, Moore WH, Ford PV, Fisher RE, Lee V-V, Alfaro-Franco C, Dhekne RD. Prognostic value of myocardial perfusion imaging in patients with high exercise tolerance. Circulation. 1999;99: 867-872.
33. O'Keefe JH Jr, Bateman TM, Ligon RW, Case J, Cullom J, Barnhart C, Spertus J. Outcome of medical versus invasive treatment strategies for non-high-risk ischemic heart disease. J Nucl Cardiol. 1998;5:28-33.
34. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, Friedman J, Diamond GA. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction [published erratum appears in Circulation. 1998;98:190-191]. Circulation. 1998;97:535-543.
35. Hachamovitch R, Berman DS, Kiat H, Cohen I, Lewin H, Amanullah A, Kang X, Friedman J, Diamond GA. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol. 1997;80: 426-433.
36. Shaw LJ, Hachamovitch R, Berman DS, Marwick TH, Lauer MS, Heller GV, Iskandrian AE, Kesler KL, Travin MI, Lewin HC, Hendel RC, Borges-Neto S, Miller DD. The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia: the Economics of Noninvasive Diagnosis (END) Multicenter Study Group. J Am Coll Cardiol. 1999;33:661-669.
37. Brown KA, Rowen M. Prognostic value of a normal exercise myocardial perfusion imaging study in patients with angiographically significant coronary artery disease. Am J Cardiol. 1993;71:865-867.
38. Brown KA. Prognostic value of myocardial perfusion imaging: state of the art and new developments. J Nucl Cardiol. 1996;3:516-537.
39. Verani MS. Risk stratifying patients who survive an acute myocardial infarction. J Nucl Cardiol. 1998;5:96-108.
40. Beller GA. Risk stratification after acute myocardial infarction by using noninvasive radionuclide imaging. In: Zaret BL, Beller GA, eds. Nuclear Cardiology: State of the Art and Future Directions. 2nd ed. St Louis, Mo; Mosby; 1999:451-467.
41. Beller GA. Risk stratification after acute myocardial infarction in the thrombolytic era. Eur Heart J. 1997;18:886-888.
42. Beller GA, Brown KA. The VANQWISH trial: support for the noninvasive strategy for risk stratification after acute myocardial infarction. J Nucl Cardiol. 1998;5:634-642.
43. Shaw LJ, Peterson ED, Kesler K, Hasselblad V, Califf RM. A meta-analysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. Am J Cardiol. 1996;78:1327-1337.
44. Gibson RS, Watson DD, Craddock GB, Crampton RS, Kaiser DL, Denny MJ, Beller GA. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation. 1983;68:321-336.
45. Boden WE, O'Rourke RA, Crawford MH, Blaustein AS, Deedwania PC, Zoble RG, Wexler LF, Kleiger RE, Pepine CJ, Ferry DR, Chow BK, Lavori PW. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy: Veterans Affairs Non-Q-Wave Infarction Strategies in Hospital (VANQWISH) Trial Investigators [published erratum appears in N Engl J Med. 1998;339:1091]. N Engl J Med. 1998;338:1785-1792.
46. 201T1 tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation. 1996;94:2735-2742.
47. Travin MI, Dessouki A, Cameron T, Heller GV. Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol. 1995;75:665-669.
48. Brown KA, O'Meara J, Chambers CE, Plante DA. Ability of dipyridamole-thallium-201 imaging one to four days after acute myocardial infarction to predict in-hospital and late recurrent myocardial ischemic events. Am J Cardiol. 1990;65:160-167.
49. 99mTc-sestamibi single photon emission computed tomographic imaging 2-4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation. 1999;100: 2060-2066.
50. Haas F, Haehnel CJ, Picker W, Nekolla S, Martinoff S, Meisner H, Schwaiger M. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol. 1997;30: 1693-1700.
51. Sciagra R, Bisi G, Santoro GM, Zerauschek F, Sestini S, Pedenovi P, Pappagallo R, Fazzini PF. Comparison of baseline-nitrate technetium-99m sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol. 1997;30:384-391.
52. Bonow RO. Identification of viable myocardium. Circulation. 1996;94: 2674-2680.
53. Beller GA. Selecting patients with ischemic cardiomyopathy for medical treatment, revascularization, or heart transplantation. J Nucl Cardiol. 1997;4(suppl):S152-S157.
54. Udelson JE. Steps forward in the assessment of myocardial viability in left ventricular dysfunction. Circulation. 1998;97:833-838.
55. 201T1 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation. 1993;87:1630-1641.
56. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti PM. Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol. 1997;30:1451-1460.
57. 99mTc-sestamibi. Circulation. 1994;89:2552-2561.
58. Kauffman GJ, Boyne TS, Watson DD, Smith WH, Beller GA. Comparison of rest thallium-201 imaging and rest technetium-99m sestamibi imaging for assessment of myocardial viability in patients with coronary artery disease and severe left ventricular dysfunction. J Am Coll Cardiol. 1996;27:1592-1597.
59. Galassi AR, Tamburino C, Grassi R, Foti R, Mammana C, Virgilio A, Licciardello G, Musumeci S, Giuffrida G. Comparison of technetium-99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction. J Nucl Cardiol. 1998;5: 56-63.
60. Schelbert HR. The usefulness of positron emission tomography. Curr Probl Cardiol. 1998;23:69-120.
61. Bax JJ, Cornel JH, Visser FC, Fioretti PM, van Lingen A, Huitink JM, Kamp O, Nijland F, Roelandt JR, Visser CA. Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography. J Am Coll Cardiol. 1997;30:377-383.
62. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation. 1997;96: 793-800.
63. Pasquet A, Robert A, D'Hondt AM, Dion R, Melin JA, Vanoverschelde JL. Prognostic value of myocardial ischemia and viability in patients with chronic left ventricular ischemic dysfunction. Circulation. 1999; 100:141-148.
64. Gioia G, Powers J, Heo J, Iskandrian AS. Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy. Am J Cardiol. 1995;75:759-762.
65. Eitzman D, al-Aouar Z, Kanter HL, vom Dahl J, Kirsh M, Deeb GM, Schwaiger M. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol. 1992;20:559-565.
66. DiCarli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC, Czernin J, Rokhsar S, Stevenson LW, Laks H, Hawkins R, Schelbert HR, Phelps ME, Maddahi J. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol. 1994;73: 527-533.
67. DiCarli MF, Asgarzadi EF, Schelbert HR, Brunken RC, Laks H, Phelps ME, Maddahi J. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation. 1995;92: 3436-3444.
68. Marwick TH, Zuchowski C, Lauer MS, Secknus MA, Williams J, Lytle BW. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Call Cardiol. 1999;33:750-758.
69. Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE. Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion: Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med. 1993;329:1677-1683.
70. Leor J, Poole WK, Kloner RA. Sudden cardiac death triggered by an earthquake. N Engl J Med. 1996;334:413-419.
71. Rozanski A, Bairey CN, Krantz DS, Friedman J, Resser KJ, Morell M, Hilton-Chalfen S, Hestrin L, Bietendorf J, Herman DS. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N Engl J Med. 1988;318:1005-1012.
72. Burg MM, Jain D, Soufer R, Kerns RD, Zaret BL. Role of behavioral and psychological factors in mental-stress induced silent left ventricular dysfunction in coronary artery disease. J Am Coll Cardiol. 1993;22: 440-448.
73. Blumenthal JA, Jiang W, Waugh RA, Frid DJ, Morris JJ, Coleman RE, Hanson M, Babyak M, Thyrum ET, Krantz DS, O'Connor C. Mental stress-induced ischemia in the laboratory and ambulatory ischemia during daily life: association and hemodynamic features. Circulation. 1995;92:2102-2108.
74. Jain D, Burg M, Soufer R, Zaret BL. Prognostic implications of mental stress induced silent left ventricular dysfunction in patients with stable angina pectoris. Am J Cardiol. 1995;76:31-35.
75. Jiang W, Babyak M, Krantz DS, Waugh RA, Coleman E, Hanson MM, Frid DJ, McNulty S, Morris JJ, O'Connor CM, Blumenthal JA. Mental stress-induced myocardial ischemia and cardiac events. JAMA. 1996; 275:1651-1656.
76. Goldberg AD, Becker LC, Bonsall R, Cohen JD, Ketterer MW, Kaufman PG, Krantz DS, Light KC, McMahon RP, Noreuil T, Pepine CJ, Raczynski J, Stone PH, Strother D, Taylor H, Sheps DS. Ischemic, hemodynamic, and neurohormonal responses to mental and exercise stress: experience from the Psychophysiological Investigations of Myocardial Ischemia Study (PIMI). Circulation. 1996;94:2402-2409.
77. Jain D, Shaker SM, Burg M, Wackers FJ, Soufer R, Zarel BL. Effects of mental stress on left ventricular and peripheral vascular performance in patients with coronary artery disease. J Am Coll Cardiol. 1998;31: 1314-1322.
78. Andrews TC, Parker JD, Jacobs S, Friedman R, Cummings N, MacCallum G, Mannting F, Tofler GH, Carlson W, Muller JE, Stone PH. Effects of therapy with nifedipine GITS or atenolol on mental stress-induced ischemic left ventricular dysfunction. J Am Coll Cardiol. 1998;32:1680-1686.
79. Watson DD, Germano G, DePuey EG, Ficaro E, Garcia E, Gulberg GT, Williams KA, King M, Cullom J, Bacharach S. Wintergreen Panel summaries: Panel on Instrumentation and Quantification. J Nucl Cardiol. 1999;6:94-103.
80. Germano G, Kiat H, Kavanagh PB, Moriel M, Mazzanti M, Su HT, Van Train KF, Berman DS. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med. 1995;36: 2138-2147.
81. Sharir T, Germano G, Kavanagh PB, Lai S, Cohen I, Lewin HC, Friedman JD, Zcllweger MJ, Berman DS. Incremental prognostic value of poststress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation. 1999;100:1035-1042.
82. Corbett JR, Ficaro EP. Clinical review of attenuation-corrected cardiac SPECT. J Nucl Cardiol. 1999;6:54-68.
83. Sandler MP, Patton JA. Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: an alternative for determining myocardial viability. J Nucl Cardiol. 1996;3:342-349.
84. Bax JJ, Visser FC, Blanksma PK, Veening MA, Tan ES, Willemsen TM, van Lingen A, Teule GJ, Vaalburg W, Lie KI, Vesser CA. Comparison of myocardial uptake of fluorine-18 fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium. J Nucl Med. 1996;37: 1631-1636.
85. Srinivasan G, Kitsiou AN, Bacharach SL, Bartlett ML, Miller-Davis C, Dilsizian V. [F-18]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial tomography? Circulation. 1998;97:843-850.
86. Bateman TM, Cullom J, Case JA. Wide area networking in nuclear cardiology. J Nucl Cardiol. 1999;6:211-218.
87. Sinusas AJ. New approaches to myocardial imaging with hypoxia markers. In: Iskandrian AS, ed. New Developments in Cardiac Nuclear Imaging. Armonk, NY: Futura Publishing Co; 1998:203-218.
88. Okada RD, Johnson G III, Nguyen KN, Carlson LR, Beju D. HL-91-technetium-99m: a new marker of viability in ischemic myocardium. J Nucl Cardiol. 1999;6:306-315.
89. Tamaki N, Kudoh T, Tadamura E. Fatty acid imaging. In: Zaret BL, Beller GA, eds. Nuclear Cardiology: State of the Art and Future Directions. 2nd ed. St Louis, Mo: Mosby; 1999:573-586.
90. Merlet P, Valette H, Dubois-Rande JL, Moyse D, Duboc D, Dove P, Bourguignon MH, Benvenuti C, Duval AM, Agostini D. Prognostic valve of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
91. 99mTc-labeled glucarate. Circulation. 1997;95: 1577-1584.
92. 2 specific for the proliferating smooth muscle cells of human atheroma: imaging with conventional and negative charge-modified antibody fragments. Circulation. 1995;92:474-484.
93. Carrio I, Pieri PL, Narula J, Prat L, Riva P, Pedrini L, Pretolani E, Caruso G, Sarti G, Estorch M, Berna L, Riambau V, Matias-Guiu X, Pak C, Ditlow C, Chen F, Khaw BA. Noninvasive localization of human atherosclerotic lesions with indium 111-labeled monoclonal Z2D3 antibody specific for proliferating smooth muscle cells. J Nucl Cardiol. 1998;5:551-557.
94. 99mTc-labeled diadenosine tetraphosphates. Proc Natl Acad Sci USA. 1998;95:691-695.
95. Dinkelborg LM, Duda SH, Hanke H, Tepe G, Hilger CS, Semmler W. Molecular imaging of atherosclerosis using a technetium-99m-labeled endothelin derivative. J Nucl Med. 1998;39:1819-1822.
96. Lees RS, Lees AM, Strauss HW. External imaging of human atherosclerosis. J Nucl Med. 1983;24:154-156.
97. Tsimikas S, Palinski W, Halpern SE, Yeung DW, Curtiss LK, Witztum JL. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo. J Nucl Cardiol. 1999; 6:41-53.
98. Narula J, Virmani R, Iskandrian AE. Strategic targeting of atherosclerotic lesions. J Nucl Cardiol. 1999;6:81-90.
99. Villanueva FS, Jankowski RJ, Klibanov S, Pina ML, Alber SM, Watkins SC, Wagner WF. Microbubbles targeted to intercellular adhesion molecule-1 bind to activated coronary artery endothelial cells: a novel approach to assessing endothelial function using myocardial contrast echocardiography. Circulation. 1998;98:1-5.
100. 3-targeted magnetic resonance imaging. Nat Med. 1998;4:623-626.
101. Blankenberg FG, Katsikis PD, Tait JF, Davis E, Naumovski L, Ohtsuki K, Kopiwoda S, Abrams MJ, Darkes M, Robbins RC, Maecker HT, Strauss HW. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci U S A. 1998;95:6349-6354.
102. Gambhir SS, Barrio JR, Herschman HR, Phelps ME. Imaging gene expression: principles and assays. J Nucl Cardiol. 1999;6:219-233.
103. Dewanjee MK, Haider N, Narula J. Imaging with radiolabeled antisense oligonucleotides for the detection of intracellular messenger RNA and cardiovascular disease. J Nucl Cardiol. 1999;6:345-356.
104. Gambhir SS, Barrio JR, Phelps ME, Iyer M, Namavari M, Satyamurthy N, Wu L, Green LA, Bauer E, MacLaren DC, Nguyen K, Berk AJ, Cherry SR, Herschman HR. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography. Proc Natl Acad Sci U S A. 1999;96:2333-2338.
105. Weber DA, Ivanovic M. Ultra-high resolution imaging of small animals: implications for preclinical and research studies. J Nucl Cardiol. 1999;6:332-344.